日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

IGFBP3-SphK1/S1P Signaling Axis Drives Enzalutamide Resistance in Advanced Prostate Cancer

IGFBP3-SphK1/S1P信号轴驱动晚期前列腺癌的恩扎卢胺耐药性

Leslie, Amy R; Ning, Shu; Sharifi, Masuda; Schaaf, Zachary A; Maine, James P; Lou, Wei; Leslie, Kristina D; Liu, Chengfei; Xu, Hongyu; Lombard, Alan P; Chen, Hong-Wu; Parikh, Mamta; Dall'Era, Marc; Gao, Allen C

LX1 Dual Targets AR Variants and AKR1C3 in Advanced Prostate Cancer Therapy.

LX1 双靶点 AR 变异体和 AKR1C3 在晚期前列腺癌治疗中的应用

Ning Shu, Armstrong Cameron M, Xing Enming, Leslie Amy R, Gao Richard Y, Sharifi Masuda, Schaaf Zachary A, Lou Wei, Han Xiangrui, Xu Desiree H, Yang Rui, Cheng Jeffrey, Mohammed Shabber, Mitsiades Nicholas, Liu Chengfei, Lombard Alan P, Wu Chun-Yi, Cheng Xiaolin, Li Pui-Kai, Gao Allen C

Therapeutic Resistance Models and Treatment Sequencing in Advanced Prostate Cancer

晚期前列腺癌的治疗耐药模型和治疗顺序

Schaaf, Zachary A; Ning, Shu; Leslie, Amy R; Sharifi, Masuda; Han, Xianrui; Armstrong, Cameron; Lou, Wei; Lombard, Alan P; Liu, Chengfei; Gao, Allen C

Resistance Mechanisms to Taxanes and PARP Inhibitors in Advanced Prostate Cancer

晚期前列腺癌对紫杉烷类和PARP抑制剂的耐药机制

Lombard, Alan P; Gao, Allen C